More information at www.walescancerconference.org
The Experimental Cancer Medicine Centre
Members of the Wales Cancer Institute have successfully bid for the Wales Experimental Cancer Medicine Centre (ECMC) aiming to turn scientific discoveries into treatments as quickly as possible. Receiving £287,000 a year for the next five years the centre will focus on bringing new agents and molecular markers to clinical trials.
Professor Alan Burnett, Head of the Haematology Department at the School of Medicine Cardiff University led the bid. He has already conducted a number of successful projects which have translated laboratory research into clinical trials of leukaemia treatments. Professor Burnett’s work has included the development of an agent which targets one of the most common gene mutations causing acute adult leukaemia. Pre-clinical work has shown it to work on human cells and a patient trial is now under way. The ECMC will take Professor Burnett’s development system and apply it to other forms of cancer.
Professor Burnett is collaborating with colleagues in Cardiff and across Wales to identify other areas which can be developed through the ECMC with potential candidates in prostate, breast and colo-rectal cancer.
Co-investigators on this project include colleagues from the Schools of Pharmacy and Bioscience at Cardiff University and from the South West Wales Cancer Institute and Velindre NHS Trust.
Collaborating in Cancer Research Conference 2006
The "Collaborating in Cancer Research Conference 2006" took place
on 8th and 9th March at the Millennium Stadium and was deemed a great
success. This was the inaugural conference of the Wales Cancer Institute,
a central partnership of clinicians, scientists, charities and government
bodies which aims to translate the quality research being conducted
in the laboratories and clinical trials into new cancer drugs and
treatments for patients more quickly and more effectively.
Up to 300 delegates from across the UK came together to listen to keynote speeches and discussions on subjects ranging from human cancer tissue donation to the very latest drugs being trialed for the frontline fight against the disease.
On day one Prof Julian Peto gave his keynote speech on "An epidemiological perspective on the biology of cancer" before colleagues from around Wales updated the audience on current work in both basic science and clinical cancer research. The day ended with a debate on the drug Herceptin with the audience voting on the motion that "This house believes that all new cancer drugs should be available for patients on the NHS as soon as they are licensed". Following on from her sit-in at the new Welsh Assembly Government building Mrs Jayne Sullivan put the patient perspective across. Prof Robert Leonard from Swansea gave the clinicians perspective and Dr Geoffrey Carroll from the Health Commission Wales gave the commissioners perspective.
Day two began with a series of talks on Tissue Banking including Dr Nick Zeps, Director of the Western Australia Research Tissue Network talking on "Tissue Banking - why bother".
This was followed by individual sessions on Breast Cancer, Prostate Cancer, Palliative Care, Informed Consent, Haematology, Colorectal Cancer and Screening, Prevention and Primary Care.
Sara Edwards of BBC's Wales Today chaired a lively question and answer session "Cancer Research under the Microscope" where patients attending the conference could put their questions on cancer research to a panel of a clinician, scientist and research nurse.
The conference ended with a keynote speech from Dr Richard Sullivan of Cancer Research UK who talked about CRUK's vision for cancer research in the UK.
Prof David Wynford Thomas, Dean of Medicine at Cardiff University and lead for the Wales Cancer Institute said "The conference lived up to our expectations and provided a fantastic spring board for the future work of the institute across Wales"
Please find below some of the presentations from the plenary sessions at the conference. Presentations from the break-out sessions to follow. Please click on the links to download and view the presentations.
'An epidemiological perspective on the biology of cancer.'
Professor Julian Peto, Cancer Research UK Chair of Epidemiology at the London School of Hygiene & Tropical Medicine and the Institute of Cancer Research.
'Basic research and understanding cancer proneness: the role of DNA repair'
Prof Ray Waters - Cardiff University, Pathology Dept
'Age, Cancer and the repair of broken chromosomes'
Dr Thomas Caspari, North West Cancer Research Fund Institute, University of Bangor
'Treatment of Advanced colorectal cancer: bedside and bench'
Prof Tim Maughan, Velindre Hospital
Prof Jim Cassidy, CRUK Dept Medical Oncology, University of Glasgow
'The Issue of Tissue' - Cancer Banking for Research'
Dr Gerry Thomas, Swansea University
'Bioinformatics - plus and minuses'
Dr Paul Lewis, Swansea University
'Tissue banking - why bother!?!'
Dr Nik Zeps, Director, Western Australian Research Tissue Network
'Current trials in prostate cancer'
Prof Malcolm Mason, CRW Professor of Clinical Oncology